Cargando…

Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma

Glioblastoma (GBM) is an extremely aggressive tumor of the central nervous system, with a prognosis of 12–15 months and just 3–5% of survival over 5 years. This is mainly because most patients suffer recurrence after treatment that currently consists in maximal resection followed by radio- and chemo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fedele, Monica, Cerchia, Laura, Pegoraro, Silvia, Sgarra, Riccardo, Manfioletti, Guidalberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600373/ https://www.ncbi.nlm.nih.gov/pubmed/31167470 http://dx.doi.org/10.3390/ijms20112746

Ejemplares similares

The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
por: Fedele, Monica, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness
por: Pegoraro, Silvia, et al.
Publicado: (2015)

Identification and Characterization of New Molecular Partners for the Protein Arginine Methyltransferase 6 (PRMT6)
por: Lo Sardo, Alessandra, et al.
Publicado: (2013)

Correction: Identification and Characterization of New Molecular Partners for the Protein Arginine Methyltransferase 6 (PRMT6)
por: Lo Sardo, Alessandra, et al.
Publicado: (2013)

ME2 Promotes Proneural–Mesenchymal Transition and Lipogenesis in Glioblastoma
por: Yang, Mengting, et al.
Publicado: (2021)

HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion
por: Ros, Gloria, et al.
Publicado: (2020)

Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes
por: Keller, Maureen, et al.
Publicado: (2022)

Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma
por: Chen, Zhihong, et al.
Publicado: (2023)

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype
por: Guadagno, Elia, et al.
Publicado: (2017)

HMGA1 Regulates the Expression of Replication-Dependent Histone Genes and Cell-Cycle in Breast Cancer Cells
por: Petrosino, Sara, et al.
Publicado: (2022)

USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma
por: Qiu, Wenjin, et al.
Publicado: (2023)

A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin
por: Arnoldo, Laura, et al.
Publicado: (2015)

HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel
por: Sgubin, Michela, et al.
Publicado: (2022)

HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness
por: Pegoraro, Silvia, et al.
Publicado: (2013)

Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor
por: Chiefari, Eusebio, et al.
Publicado: (2018)

HMGA1 Modulates Gene Transcription Sustaining a Tumor Signalling Pathway Acting on the Epigenetic Status of Triple-Negative Breast Cancer Cells
por: Penzo, Carlotta, et al.
Publicado: (2019)

High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network
por: Sgarra, Riccardo, et al.
Publicado: (2020)

Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
por: Abelli, Joaquin, et al.
Publicado: (2022)

A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma
por: Qi, Tengfei, et al.
Publicado: (2021)

The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair
por: Pellarin, Ilenia, et al.
Publicado: (2016)

HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells
por: Resmini, Giulia, et al.
Publicado: (2017)

Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
por: Lai, Yancheng, et al.
Publicado: (2023)

RBPJ contributes to the malignancy of glioblastoma and induction of proneural‐mesenchymal transition via IL‐6‐STAT3 pathway
por: Zhang, Guangtao, et al.
Publicado: (2020)

Infection prevention for open fractures: Is antibiotic monotherapy equivalent to multitherapy?
por: Miller, Andrew C., et al.
Publicado: (2019)

The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
por: Fedele, Monica, et al.
Publicado: (2017)

Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature
por: Steponaitis, Giedrius, et al.
Publicado: (2021)

Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype
por: Lei, Liang, et al.
Publicado: (2011)

Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer
por: Maurizio, Elisa, et al.
Publicado: (2016)

Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition
por: Thuault, Sylvie, et al.
Publicado: (2006)

HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1
por: Zanin, Rossella, et al.
Publicado: (2019)

Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma
por: Lin, Zhiying, et al.
Publicado: (2022)

The High Mobility Group A1 (HMGA1) Chromatin Architectural Factor Modulates Nuclear Stiffness in Breast Cancer Cells
por: Senigagliesi, Beatrice, et al.
Publicado: (2019)

Expression and Functional Characterization of Xhmg-at-hook Genes in Xenopus laevis
por: Macrì, Simone, et al.
Publicado: (2013)

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme
por: Brown, Daniel V., et al.
Publicado: (2015)

Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors
por: Kaffes, Ioannis, et al.
Publicado: (2019)

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
por: Gao, Zijie, et al.
Publicado: (2022)

A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
por: Stringer, Brett W., et al.
Publicado: (2019)

Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma
por: Sharma, Aman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o8eoothuqk40b0fmqgdvqsu137